These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 24072169)

  • 1. Mutation rate and the emergence of drug resistance in Mycobacterium tuberculosis.
    McGrath M; Gey van Pittius NC; van Helden PD; Warren RM; Warner DF
    J Antimicrob Chemother; 2014 Feb; 69(2):292-302. PubMed ID: 24072169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-resistant tuberculosis: resistance mechanisms and rapid susceptibility testing.
    Pfyffer GE
    Schweiz Med Wochenschr; 2000 Dec; 130(49):1909-13. PubMed ID: 11153397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of drug resistance in Mycobacterium tuberculosis.
    Zhang Y; Yew WW
    Int J Tuberc Lung Dis; 2009 Nov; 13(11):1320-30. PubMed ID: 19861002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of multiple and extensively drug resistant Mycobacterium tuberculosis isolates with different ofloxacin-resistance levels.
    Chernyaeva E; Fedorova E; Zhemkova G; Korneev Y; Kozlov A
    Tuberculosis (Edinb); 2013 May; 93(3):291-5. PubMed ID: 23491718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fitness of acquired drug resistant Mycobacterium tuberculosis isolates from DOTS compliant patients.
    Bhatter P; Mistry N
    Tuberculosis (Edinb); 2013 Jul; 93(4):418-24. PubMed ID: 23615069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mycobacterium tuberculosis mutants with multidrug resistance: history of origin, genetic and molecular mechanisms of resistance, and emerging challenges].
    Prozorov AA; Zaĭchikova MV; Danilenko VN
    Genetika; 2012 Jan; 48(1):5-20. PubMed ID: 22567849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Further acquisition of drug-resistance in multidrug-resistant tuberculosis during chemotherapy.
    Toyota E; Sekiguchi J; Shimizu H; Fujino T; Otsuka Y; Yoshikura H; Kuratsuji T; Kirikae T; Kudo K
    Jpn J Infect Dis; 2004 Dec; 57(6):292-4. PubMed ID: 15623961
    [No Abstract]   [Full Text] [Related]  

  • 10. [Detection of genes associated with drug resistance in Mycobacterium tuberculosis strains isolated in Chile].
    Araya P; Velasco M; Tognarelli J; Arias F; Leiva T; Sccapatticio A; Alviz P; Fernández J
    Rev Med Chil; 2011 Apr; 139(4):467-73. PubMed ID: 21879185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of genotype MTBDR assay for molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis clinical strains isolated in Italy.
    Miotto P; Piana F; Penati V; Canducci F; Migliori GB; Cirillo DM
    J Clin Microbiol; 2006 Jul; 44(7):2485-91. PubMed ID: 16825369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Directed mutagenesis of Mycobacterium smegmatis 16S rRNA to reconstruct the in vivo evolution of aminoglycoside resistance in Mycobacterium tuberculosis.
    Shcherbakov D; Akbergenov R; Matt T; Sander P; Andersson DI; Böttger EC
    Mol Microbiol; 2010 Aug; 77(4):830-40. PubMed ID: 20545852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A proportion of mutations fixed in the genomes of in vitro selected isogenic drug-resistant Mycobacterium tuberculosis mutants can be detected as minority variants in the parent culture.
    Bergval I; Coll F; Schuitema A; de Ronde H; Mallard K; Pain A; McNerney R; Clark TG; Anthony RM
    FEMS Microbiol Lett; 2015 Jan; 362(2):1-7. PubMed ID: 25670707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of heteroresistance to isoniazid and rifampin of Mycobacterium tuberculosis in Tashkent, Uzbekistan.
    Hofmann-Thiel S; van Ingen J; Feldmann K; Turaev L; Uzakova GT; Murmusaeva G; van Soolingen D; Hoffmann H
    Eur Respir J; 2009 Feb; 33(2):368-74. PubMed ID: 18829680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid direct detection of multiple rifampin and isoniazid resistance mutations in Mycobacterium tuberculosis in respiratory samples by real-time PCR.
    Marín M; García de Viedma D; Ruíz-Serrano MJ; Bouza E
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4293-300. PubMed ID: 15504855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of multidrug resistance in Mycobacterium tuberculosis.
    Sekiguchi J; Miyoshi-Akiyama T; Augustynowicz-Kopeć E; Zwolska Z; Kirikae F; Toyota E; Kobayashi I; Morita K; Kudo K; Kato S; Kuratsuji T; Mori T; Kirikae T
    J Clin Microbiol; 2007 Jan; 45(1):179-92. PubMed ID: 17108078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance to antimicrobial agents in Mycobacterium tuberculosis.
    Pfyffer GE
    Acta Cient Venez; 2001; 52 Suppl 1():36-9. PubMed ID: 11899703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular snapshot of drug-resistant and drug-susceptible Mycobacterium tuberculosis strains circulating in Bulgaria.
    Valcheva V; Mokrousov I; Narvskaya O; Rastogi N; Markova N
    Infect Genet Evol; 2008 Sep; 8(5):657-63. PubMed ID: 18657631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Multidrug-resistant tuberculosis].
    Abe C
    Nihon Rinsho; 2003 Mar; 61 Suppl 3():202-6. PubMed ID: 12717972
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug resistance mechanism of PncA in Mycobacterium tuberculosis.
    Rajendran V; Sethumadhavan R
    J Biomol Struct Dyn; 2014; 32(2):209-21. PubMed ID: 23383724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.